Symbols / RCEL Stock $4.23 -2.31% AVITA Medical, Inc.
RCEL (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
No company description available for this symbol.
Ratings
- Burn care tool cleared for sale in Australia and New Zealand - Stock Titan Wed, 29 Apr 2026 20
- Avita Medical (RCEL) Secures Certification for Recell Go in Aust - GuruFocus Wed, 29 Apr 2026 22
- Avita Medical (RCEL) Soars 14.1%: Is Further Upside Left in the Stock? - Yahoo Finance Wed, 15 Apr 2026 07
- Avita Medical (RCEL) upgraded to buy: Here's what you should know - MSN Fri, 24 Apr 2026 21
- AVITA Medical stock gains on BARDA contract (RCEL:NASDAQ) - Seeking Alpha hu, 09 Apr 2026 07
- AVITA Medical schedules May 14 earnings release, 1:30 p.m. call - Stock Titan hu, 23 Apr 2026 20
- Is Avita Medical (RCEL) stock overpriced relative to performance (Trades Higher) 2026-04-18 - Professional Trade Ideas - Cổng thông tin điện tử Tỉnh Sơn La Sun, 19 Apr 2026 05
- Wall Street Analysts Believe Avita Medical (RCEL) Could Rally 29.87%: Here's is How to Trade - Yahoo Finance Wed, 25 Feb 2026 08
- AVITA Medical up on Cohealyx data on grafting (RCEL:NASDAQ) - Seeking Alpha ue, 14 Apr 2026 07
- Avita Medical Ltd stock tumbles after CEO exit and Board shake-up - MSN Sat, 25 Apr 2026 08
- The pioneer behind spray-on skin wins burn care’s top honor - Stock Titan Wed, 15 Apr 2026 07
- AVITA Medical, Inc.'s (NASDAQ:RCEL) Shift From Loss To Profit - Yahoo Finance hu, 29 Jan 2026 08
- AVITA Medical: Why The BARDA Rally Changes Nothing (NASDAQ:RCEL) - Seeking Alpha hu, 09 Apr 2026 07
- Skin grafts in 11 days: AVITA posts interim Cohealyx wound data - Stock Titan ue, 14 Apr 2026 07
- What To Expect From AVITA Medical Inc (RCEL) Q3 2025 Earnings - Yahoo Finance Wed, 05 Nov 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
71.61
+11.45%
|
64.25
+28.14%
|
50.14
+45.68%
|
34.42
|
| Operating Revenue |
|
71.61
+11.45%
|
64.25
+28.14%
|
50.14
+45.68%
|
34.42
|
| Cost Of Revenue |
|
12.79
+40.69%
|
9.09
+16.89%
|
7.78
+28.79%
|
6.04
|
| Reconciled Cost Of Revenue |
|
12.79
+40.69%
|
9.09
+16.89%
|
7.78
+28.79%
|
6.04
|
| Gross Profit |
|
58.82
+6.63%
|
55.16
+30.20%
|
42.36
+49.27%
|
28.38
|
| Operating Expense |
|
101.35
-9.31%
|
111.75
+31.44%
|
85.02
+52.13%
|
55.88
|
| Research And Development |
|
20.84
+2.35%
|
20.36
-2.21%
|
20.82
+50.26%
|
13.86
|
| Selling General And Administration |
|
80.51
-11.90%
|
91.39
+39.26%
|
65.62
+45.05%
|
45.24
|
| Selling And Marketing Expense |
|
53.14
-8.69%
|
58.20
+56.06%
|
37.29
+70.18%
|
21.91
|
| General And Administrative Expense |
|
27.37
-17.54%
|
33.20
+17.16%
|
28.33
+21.45%
|
23.33
|
| Other Gand A |
|
27.37
-17.54%
|
33.20
+17.16%
|
28.33
+21.45%
|
23.33
|
| Other Operating Expenses |
|
—
|
—
|
-1.43
+55.58%
|
-3.21
|
| Total Expenses |
|
114.14
-5.54%
|
120.84
+30.22%
|
92.80
+49.85%
|
61.93
|
| Operating Income |
|
-42.53
+24.84%
|
-56.59
-32.68%
|
-42.66
-55.08%
|
-27.50
|
| Total Operating Income As Reported |
|
-42.53
+24.84%
|
-56.59
-32.68%
|
-42.66
-55.08%
|
-27.50
|
| EBITDA |
|
-41.23
+25.46%
|
-55.30
-64.89%
|
-33.54
-28.78%
|
-26.05
|
| Normalized EBITDA |
|
-41.23
+25.46%
|
-55.30
-64.89%
|
-33.54
-28.78%
|
-26.05
|
| Reconciled Depreciation |
|
2.35
+108.44%
|
1.13
+78.16%
|
0.63
+11.27%
|
0.57
|
| EBIT |
|
-43.57
+22.79%
|
-56.43
-65.14%
|
-34.17
-28.40%
|
-26.61
|
| Net Income |
|
-48.59
+21.44%
|
-61.84
-74.80%
|
-35.38
-32.69%
|
-26.66
|
| Pretax Income |
|
-48.58
+21.39%
|
-61.79
-74.97%
|
-35.31
-32.62%
|
-26.63
|
| Net Non Operating Interest Income Expense |
|
-5.00
+6.66%
|
-5.36
-369.03%
|
-1.14
-7043.75%
|
-0.02
|
| Interest Expense Non Operating |
|
5.00
-6.66%
|
5.36
+369.03%
|
1.14
+7043.75%
|
0.02
|
| Net Interest Income |
|
-5.00
+6.66%
|
-5.36
-369.03%
|
-1.14
-7043.75%
|
-0.02
|
| Interest Expense |
|
5.00
-6.66%
|
5.36
+369.03%
|
1.14
+7043.75%
|
0.02
|
| Other Income Expense |
|
-1.04
-736.81%
|
0.16
-98.08%
|
8.48
+851.01%
|
0.89
|
| Other Non Operating Income Expenses |
|
-1.04
-736.81%
|
0.16
-98.08%
|
8.48
+851.01%
|
0.89
|
| Tax Provision |
|
0.01
-79.63%
|
0.05
-18.18%
|
0.07
+83.33%
|
0.04
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-48.59
+21.44%
|
-61.84
-74.80%
|
-35.38
-32.69%
|
-26.66
|
| Net Income From Continuing Operation Net Minority Interest |
|
-48.59
+21.44%
|
-61.84
-74.80%
|
-35.38
-32.69%
|
-26.66
|
| Net Income From Continuing And Discontinued Operation |
|
-48.59
+21.44%
|
-61.84
-74.80%
|
-35.38
-32.69%
|
-26.66
|
| Net Income Continuous Operations |
|
-48.59
+21.44%
|
-61.84
-74.80%
|
-35.38
-32.69%
|
-26.66
|
| Normalized Income |
|
-48.59
+21.44%
|
-61.84
-74.80%
|
-35.38
-32.69%
|
-26.66
|
| Net Income Common Stockholders |
|
-48.59
+21.44%
|
-61.84
-74.80%
|
-35.38
-32.69%
|
-26.66
|
| Diluted EPS |
|
-1.74
+27.20%
|
-2.39
-70.71%
|
-1.40
-30.84%
|
-1.07
|
| Basic EPS |
|
-1.74
+27.20%
|
-2.39
-70.71%
|
-1.40
-30.84%
|
-1.07
|
| Basic Average Shares |
|
27.86
+7.64%
|
25.88
+2.18%
|
25.33
+1.32%
|
25.00
|
| Diluted Average Shares |
|
27.86
+7.64%
|
25.88
+2.18%
|
25.33
+1.32%
|
25.00
|
| Diluted NI Availto Com Stockholders |
|
-48.59
+21.44%
|
-61.84
-74.80%
|
-35.38
-32.69%
|
-26.66
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
111.64
|
| Current Assets |
|
104.01
|
| Cash Cash Equivalents And Short Term Investments |
|
89.06
|
| Cash And Cash Equivalents |
|
22.12
|
| Other Short Term Investments |
|
66.94
|
| Receivables |
|
7.92
|
| Accounts Receivable |
|
7.66
|
| Gross Accounts Receivable |
|
55.66
|
| Allowance For Doubtful Accounts Receivable |
|
-48.00
|
| Other Receivables |
|
0.26
|
| Inventory |
|
5.60
|
| Raw Materials |
|
3.68
|
| Work In Process |
|
0.88
|
| Finished Goods |
|
1.03
|
| Prepaid Assets |
|
1.41
|
| Restricted Cash |
|
—
|
| Other Current Assets |
|
1.43
|
| Total Non Current Assets |
|
7.63
|
| Net PPE |
|
4.32
|
| Gross PPE |
|
6.75
|
| Accumulated Depreciation |
|
-2.43
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
2.65
|
| Construction In Progress |
|
0.09
|
| Other Properties |
|
3.65
|
| Leases |
|
0.37
|
| Goodwill And Other Intangible Assets |
|
0.49
|
| Other Intangible Assets |
|
0.49
|
| Investments And Advances |
|
0.00
|
| Other Investments |
|
—
|
| Non Current Deferred Assets |
|
—
|
| Non Current Prepaid Assets |
|
0.30
|
| Other Non Current Assets |
|
2.83
|
| Total Liabilities Net Minority Interest |
|
62.58
|
| Current Liabilities |
|
13.20
|
| Payables And Accrued Expenses |
|
11.77
|
| Payables |
|
3.79
|
| Accounts Payable |
|
3.79
|
| Current Accrued Expenses |
|
7.97
|
| Current Debt And Capital Lease Obligation |
|
0.90
|
| Current Debt |
|
—
|
| Other Current Borrowings |
|
—
|
| Current Capital Lease Obligation |
|
0.90
|
| Current Deferred Liabilities |
|
0.17
|
| Current Deferred Revenue |
|
0.03
|
| Other Current Liabilities |
|
0.37
|
| Total Non Current Liabilities Net Minority Interest |
|
49.38
|
| Long Term Debt And Capital Lease Obligation |
|
41.51
|
| Long Term Debt |
|
39.81
|
| Long Term Capital Lease Obligation |
|
1.70
|
| Defined Pension Benefit |
|
—
|
| Non Current Deferred Liabilities |
|
4.02
|
| Non Current Deferred Revenue |
|
0.36
|
| Other Non Current Liabilities |
|
—
|
| Preferred Securities Outside Stock Equity |
|
0.69
|
| Stockholders Equity |
|
49.06
|
| Common Stock Equity |
|
49.06
|
| Capital Stock |
|
0.00
|
| Common Stock |
|
0.00
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
25.68
|
| Ordinary Shares Number |
|
25.68
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
350.04
|
| Retained Earnings |
|
-297.97
|
| Gains Losses Not Affecting Retained Earnings |
|
-1.89
|
| Other Equity Adjustments |
|
-1.89
|
| Total Equity Gross Minority Interest |
|
49.06
|
| Total Capitalization |
|
88.87
|
| Working Capital |
|
90.81
|
| Invested Capital |
|
88.87
|
| Total Debt |
|
42.41
|
| Net Debt |
|
17.69
|
| Capital Lease Obligations |
|
2.60
|
| Net Tangible Assets |
|
48.57
|
| Tangible Book Value |
|
48.57
|
| Available For Sale Securities |
|
—
|
| Derivative Product Liabilities |
|
3.16
|
| Investmentin Financial Assets |
|
0.00
|
| Other Equity Interest |
|
-1.13
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-31.20
+36.26%
|
-48.94
-28.75%
|
-38.01
-99.11%
|
-19.09
|
| Cash Flow From Continuing Operating Activities |
|
-31.20
+36.26%
|
-48.94
-28.75%
|
-38.01
-99.11%
|
-19.09
|
| Net Income From Continuing Operations |
|
-48.59
+21.44%
|
-61.84
-74.80%
|
-35.38
-32.69%
|
-26.66
|
| Depreciation Amortization Depletion |
|
2.35
+108.44%
|
1.13
+78.16%
|
0.63
+11.27%
|
0.57
|
| Depreciation And Amortization |
|
2.35
+108.44%
|
1.13
+78.16%
|
0.63
+11.27%
|
0.57
|
| Other Non Cash Items |
|
3.16
-14.75%
|
3.71
-19.48%
|
4.61
+284.39%
|
1.20
|
| Pension And Employee Benefit Expense |
|
—
|
—
|
0.86
+2152.63%
|
0.04
|
| Stock Based Compensation |
|
9.52
-29.47%
|
13.50
+60.97%
|
8.38
+19.81%
|
7.00
|
| Provisionand Write Offof Assets |
|
-0.01
-143.48%
|
0.02
-4.17%
|
0.02
+580.00%
|
-0.01
|
| Asset Impairment Charge |
|
0.82
+63.22%
|
0.50
+123.56%
|
0.23
-40.00%
|
0.38
|
| Deferred Tax |
|
—
|
—
|
—
|
—
|
| Deferred Income Tax |
|
—
|
—
|
—
|
—
|
| Operating Gains Losses |
|
-1.58
-492.29%
|
0.40
+104.70%
|
-8.54
-10320.73%
|
-0.08
|
| Gain Loss On Investment Securities |
|
-2.19
-898.91%
|
0.27
-63.47%
|
0.75
|
—
|
| Net Foreign Currency Exchange Gain Loss |
|
0.02
-19.05%
|
0.02
+100.22%
|
-9.38
-10932.94%
|
-0.09
|
| Gain Loss On Sale Of PPE |
|
0.59
+456.07%
|
0.11
+28.92%
|
0.08
+2666.67%
|
0.00
|
| Change In Working Capital |
|
3.44
+173.51%
|
-4.68
+28.84%
|
-6.57
-449.67%
|
-1.20
|
| Change In Receivables |
|
3.63
+187.65%
|
-4.14
-25.45%
|
-3.30
-235.43%
|
-0.98
|
| Changes In Account Receivables |
|
3.63
+187.65%
|
-4.14
+0.65%
|
-4.17
-956.20%
|
-0.40
|
| Change In Inventory |
|
-0.47
+78.33%
|
-2.16
+41.51%
|
-3.69
-895.42%
|
-0.37
|
| Change In Prepaid Assets |
|
0.77
+306.47%
|
-0.37
+17.74%
|
-0.45
-23.22%
|
-0.37
|
| Change In Payables And Accrued Expense |
|
0.11
-96.20%
|
2.82
+30.75%
|
2.16
+38.74%
|
1.55
|
| Change In Accrued Expense |
|
-2.64
-206.41%
|
2.48
+84.04%
|
1.35
+5.90%
|
1.27
|
| Change In Payable |
|
2.75
+707.35%
|
0.34
-57.97%
|
0.81
+186.88%
|
0.28
|
| Change In Account Payable |
|
2.75
+707.35%
|
0.34
-57.97%
|
0.81
+186.88%
|
0.28
|
| Change In Other Working Capital |
|
0.05
-89.18%
|
0.42
+4.68%
|
0.41
-45.14%
|
0.74
|
| Change In Other Current Assets |
|
0.34
+173.81%
|
-0.46
+62.77%
|
-1.24
-36.98%
|
-0.91
|
| Change In Other Current Liabilities |
|
-0.99
-25.77%
|
-0.78
-75.39%
|
-0.45
+48.14%
|
-0.86
|
| Investing Cash Flow |
|
12.45
-66.67%
|
37.36
+2225.02%
|
1.61
+108.31%
|
-19.33
|
| Cash Flow From Continuing Investing Activities |
|
12.45
-66.67%
|
37.36
+2225.02%
|
1.61
+108.31%
|
-19.33
|
| Net PPE Purchase And Sale |
|
-1.00
+89.04%
|
-9.17
-564.08%
|
-1.38
-205.53%
|
-0.45
|
| Purchase Of PPE |
|
-1.00
+89.04%
|
-9.17
-564.08%
|
-1.38
-205.53%
|
-0.45
|
| Capital Expenditure |
|
-1.74
+81.37%
|
-9.33
-544.99%
|
-1.45
-175.62%
|
-0.53
|
| Capital Expenditure Reported |
|
-0.64
|
0.00
|
—
|
—
|
| Net Investment Purchase And Sale |
|
14.19
-69.61%
|
46.70
+1429.01%
|
3.05
+116.24%
|
-18.81
|
| Purchase Of Investment |
|
-13.31
+45.69%
|
-24.50
+68.89%
|
-78.76
-5.91%
|
-74.36
|
| Sale Of Investment |
|
27.50
-61.38%
|
71.20
-12.97%
|
81.81
+47.26%
|
55.55
|
| Net Intangibles Purchase And Sale |
|
-0.10
+38.89%
|
-0.16
-145.45%
|
-0.07
+9.59%
|
-0.07
|
| Purchase Of Intangibles |
|
-0.10
+38.89%
|
-0.16
-145.45%
|
-0.07
+9.59%
|
-0.07
|
| Financing Cash Flow |
|
14.94
+325.77%
|
3.51
-91.31%
|
40.37
+4386.00%
|
0.90
|
| Cash Flow From Continuing Financing Activities |
|
14.94
+325.77%
|
3.51
-91.31%
|
40.37
+4386.00%
|
0.90
|
| Net Issuance Payments Of Debt |
|
—
|
0.00
-100.00%
|
38.76
|
0.00
|
| Issuance Of Debt |
|
—
|
0.00
-100.00%
|
38.76
|
0.00
|
| Repayment Of Debt |
|
—
|
—
|
—
|
0.00
|
| Long Term Debt Issuance |
|
—
|
0.00
-100.00%
|
38.76
|
0.00
|
| Long Term Debt Payments |
|
—
|
—
|
—
|
0.00
|
| Net Long Term Debt Issuance |
|
—
|
0.00
-100.00%
|
38.76
|
0.00
|
| Net Common Stock Issuance |
|
14.79
|
0.00
|
—
|
0.00
|
| Proceeds From Stock Option Exercised |
|
1.20
-65.74%
|
3.51
+117.62%
|
1.61
+79.11%
|
0.90
|
| Net Other Financing Charges |
|
-1.06
|
—
|
—
|
—
|
| Changes In Cash |
|
-3.81
+52.81%
|
-8.07
-303.22%
|
3.97
+110.58%
|
-37.52
|
| Effect Of Exchange Rate Changes |
|
—
|
0.00
+100.00%
|
-0.02
+38.46%
|
-0.03
|
| Beginning Cash Position |
|
14.05
-36.48%
|
22.12
+21.77%
|
18.16
-67.40%
|
55.71
|
| End Cash Position |
|
10.24
-27.10%
|
14.05
-36.48%
|
22.12
+21.77%
|
18.16
|
| Free Cash Flow |
|
-32.93
+43.48%
|
-58.27
-47.68%
|
-39.46
-101.16%
|
-19.61
|
| Interest Paid Supplemental Data |
|
—
|
5.36
+368.85%
|
1.14
+7520.00%
|
0.01
|
| Income Tax Paid Supplemental Data |
|
—
|
0.04
-6.82%
|
0.04
+158.82%
|
0.02
|
| Amortization Of Securities |
|
-0.31
+81.60%
|
-1.67
-21.22%
|
-1.38
-391.46%
|
-0.28
|
| Common Stock Issuance |
|
14.79
|
0.00
|
—
|
0.00
|
| Issuance Of Capital Stock |
|
14.79
|
0.00
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-03-11 View
- 42026-02-23 View
- 42026-02-19 View
- 42026-02-19 View
- 10-K2026-02-12 View
- 8-K2026-02-12 View
- 8-K2026-01-13 View
- 8-K2026-01-05 View
- 10-Q2025-11-06 View
- 8-K2025-11-06 View
- 8-K2025-10-17 View
- 42025-08-29 View
- 42025-08-26 View
- 42025-08-20 View
- 8-K2025-08-18 View
- 42025-08-12 View
- 8-K2025-08-12 View
- 10-Q2025-08-08 View
- 8-K2025-08-07 View
- 8-K2025-08-06 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|